Total Payments
$24,706
2024 Payments
$193.28
Companies
33
Transactions
370
Medicare Patients
993
Medicare Billing
$102,130
Payment Breakdown by Category
Other$19,037 (77.1%)
Food & Beverage$5,266 (21.3%)
Travel$279.39 (1.1%)
Education$123.24 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,037 | 12 | 77.1% |
| Food and Beverage | $5,266 | 342 | 21.3% |
| Travel and Lodging | $279.39 | 8 | 1.1% |
| Education | $123.24 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $7,633 | 63 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $5,484 | 18 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $4,551 | 19 | $0 (2018) |
| Allergan Inc. | $2,995 | 24 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $921.58 | 82 | $0 (2021) |
| PFIZER INC. | $674.72 | 40 | $0 (2021) |
| Janssen Biotech, Inc. | $319.10 | 18 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $228.36 | 7 | $0 (2024) |
| ABBVIE INC. | $192.83 | 15 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $181.71 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.28 | 4 | Ferring Pharmaceuticals Inc. ($125.00) |
| 2023 | $125.00 | 1 | E.R. Squibb & Sons, L.L.C. ($125.00) |
| 2022 | $318.66 | 7 | Janssen Scientific Affairs, LLC ($125.00) |
| 2021 | $1,005 | 73 | Takeda Pharmaceuticals U.S.A., Inc. ($299.53) |
| 2020 | $648.37 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($214.68) |
| 2019 | $1,110 | 76 | PFIZER INC. ($320.82) |
| 2018 | $8,063 | 70 | Takeda Pharmaceuticals U.S.A., Inc. ($7,002) |
| 2017 | $13,243 | 88 | Takeda Pharmaceuticals America, Inc. ($5,484) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Nephrology | ||||||
| 10/25/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Nephrology | ||||||
| 09/11/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuroscience | ||||||
| 08/10/2022 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 06/15/2022 | MicroVention, Inc. | SOFIA 6F-131CM STR (Device), WEB ANEURYSM EMBOLIZATION SYSTEM | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROLOGICAL PRODUCT | ||||||
| 06/14/2022 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $107.04 | General |
| Category: Peripheral Intervention | ||||||
| 03/23/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 03/09/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 03/09/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 01/12/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Immunology | ||||||
| 12/16/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 12/15/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Gastroenterology | ||||||
| 12/13/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | PLENVU (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Gastroenterology | ||||||
| 11/11/2021 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Gastroenterology | ||||||
| 11/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | PLENVU (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Gastroenterology | ||||||
| 11/03/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: Gastroenterology | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: Gastroenterology | ||||||
| 10/20/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Immunology | ||||||
| 10/20/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Antibiotic | ||||||
| 10/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 36 | 40 | $11,830 | $3,279 |
| 2021 | 11 | 395 | 431 | $272,626 | $42,301 |
| 2020 | 9 | 562 | 612 | $423,499 | $56,550 |
Total Patients
993
Total Services
1,083
Medicare Billing
$102,130
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,445 | $1,270 | 36.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,300 | $1,125 | 17.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 15 | $2,085 | $883.83 | 42.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 90 | 91 | $82,628 | $10,322 | 12.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 106 | 119 | $93,772 | $7,184 | 7.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 33 | 33 | $31,614 | $6,323 | 20.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 47 | 47 | $9,494 | $3,389 | 35.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 19 | 19 | $13,509 | $3,331 | 24.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 20 | $5,480 | $2,783 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 31 | $6,293 | $2,667 | 42.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 24 | 24 | $19,776 | $2,286 | 11.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 24 | $4,800 | $1,969 | 41.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $3,720 | $1,450 | 39.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,540 | $595.89 | 38.7% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 107 | 108 | $96,678 | $13,672 | 14.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 91 | 91 | $28,378 | $9,847 | 34.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 133 | 141 | $107,588 | $7,253 | 6.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 104 | 123 | $17,144 | $6,434 | 37.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 30 | 30 | $28,218 | $5,459 | 19.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2020 | 42 | 43 | $34,382 | $4,092 | 11.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 43 | $8,660 | $3,494 | 40.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 19 | 19 | $13,355 | $3,175 | 23.8% |
| 45388 | Destruction of large bowel growths using an endoscope | Facility | 2020 | 14 | 14 | $89,096 | $3,123 | 3.5% |
About Dr. Amit Ahuja, M.D
Dr. Amit Ahuja, M.D is a Gastroenterology healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528061959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Ahuja, M.D has received a total of $24,706 in payments from pharmaceutical and medical device companies, with $193.28 received in 2024. These payments were reported across 370 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,037).
As a Medicare-enrolled provider, Ahuja has provided services to 993 Medicare beneficiaries, totaling 1,083 services with total Medicare billing of $102,130. Data is available for 3 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Alexandria, LA
- Active Since 05/31/2005
- Last Updated 08/25/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1528061959
Products in Payments
- Amitiza (Drug) $12,293
- Trulance (Drug) $4,551
- LINZESS (Drug) $2,947
- XELJANZ (Drug) $579.29
- XIFAXAN (Drug) $483.11
- STELARA (Biological) $345.24
- Entyvio (Biological) $308.01
- ENTYVIO (Biological) $244.16
- TRULANCE (Drug) $204.47
- REBYOTA (Biological) $125.00
- ZEPOSIA (Drug) $125.00
- RELISTOR ORAL (Drug) $123.53
- Cimzia (Drug) $123.35
- Linzess (Drug) $120.05
- MOTEGRITY (Drug) $110.17
- Indigo System (Device) $107.04
- DIFICID (Drug) $105.50
- LINX Reflux Management System (Device) $101.29
- REMICADE (Biological) $98.86
- Omeclamox (Drug) $97.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Alexandria
Maury Morrison, M.d, M.D
Gastroenterology — Payments: $15,676
Gastroenterology $15,676
Emad Abuhamda, Md, MD
Gastroenterology — Payments: $8,114
Gastroenterology $8,114
Craig Ellison, Md, MD
Gastroenterology — Payments: $8,064
Gastroenterology $8,064
Dr. Alan Ansher, Md, MD
Gastroenterology — Payments: $6,955
Gastroenterology $6,955
Dr. Joseph Hollier, Md, MD
Gastroenterology — Payments: $6,337
Gastroenterology $6,337
Robert Richards, M.d, M.D
Gastroenterology — Payments: $5,299
Gastroenterology $5,299